Initially, GBM expression of IDO1 was thought to positively correlate with tumor grade mediated by the metabolic effects of IDO1; however, recent work has also uncovered non-metabolic IDO1-driven pro-tumoral effects. The gene discussed is IDO1; the disease is neoplasm.